1. Home
  2. PCRX vs THFF Comparison

PCRX vs THFF Comparison

Compare PCRX & THFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$25.72

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo First Financial Corporation Indiana

THFF

First Financial Corporation Indiana

HOLD

Current Price

$62.64

Market Cap

686.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCRX
THFF
Founded
2006
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
686.6M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
PCRX
THFF
Price
$25.72
$62.64
Analyst Decision
Strong Buy
Buy
Analyst Count
7
3
Target Price
$32.86
$60.00
AVG Volume (30 Days)
892.3K
58.0K
Earning Date
11-06-2025
02-03-2026
Dividend Yield
N/A
3.59%
EPS Growth
N/A
69.68
EPS
0.47
6.25
Revenue
$716,791,000.00
$250,755,000.00
Revenue This Year
$6.24
$33.24
Revenue Next Year
$9.53
$8.15
P/E Ratio
$54.61
$9.98
Revenue Growth
3.14
31.89
52 Week Low
$18.17
$42.05
52 Week High
$27.64
$65.79

Technical Indicators

Market Signals
Indicator
PCRX
THFF
Relative Strength Index (RSI) 57.22 56.06
Support Level $25.48 $64.27
Resistance Level $27.16 $65.79
Average True Range (ATR) 1.00 1.30
MACD 0.03 -0.16
Stochastic Oscillator 57.49 41.01

Price Performance

Historical Comparison
PCRX
THFF

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About THFF First Financial Corporation Indiana

First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.

Share on Social Networks: